Digital Look

Vertex Pharmaceuticals Inc. (VRTX)

Sector:

Medicine and Biotech Research

Index:

Nasdaq 100

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

$ 57.61

Change Today:

$-7.24
52 Week High: $64.85
52 Week Low: $26.60

Currency: US Dollars
Shares Issued: 211.06m
Volume: 15,717,917

Market Cap: $12,159m
RiskGrade: 525
Beta: 0.67

Update - Vertex Pharmaceuticals Inc. is down today can you capitalise from spread betting? Find out more
Update - Vertex Pharmaceuticals Inc. is near the bottom of the Nasdaq 100 - will it stay here? Have a look at Vertex Pharmaceuticals Inc.'s chart Find out more
Update - Vertex Pharmaceuticals Inc. is a top faller in its sector - can you take advantage with spread betting? Find out more

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

1 Day Chart

6 Month Chart

More Vertex Pharmaceuticals Inc. charts

Financials

	Latest	F'cast
Div Yield	0.0%
Div Cover	n/a
Op Mrgn	8.1%
ROCE	9.0%

	Latest	F'cast
P/E	463.2
PEG	n/a
Pr/Revenue	9.7
Pr/Book	14.2

	Latest	F'cast
Revenue	883.9%
PBT	n/a
EPS	n/a
DPS	n/a

VRTX Fundamentals

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-07	199.01	(391.28)	(303.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-08	175.50	(459.85)	(327.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-09	101.89	(642.18)	(371.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-10	143.37	(754.63)	(377.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-11	1,410.63	60.44	14.00¢	237.2	n/a	n/a	n/a	0.0%

VRTX Forecasts

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-12	1,916.30	554.89	253.67¢	25.6	0.0	+1,712%	n/a	0.0%
31-Dec-13	2,008.21	641.05	261.17¢	24.8	8.4	+3%	n/a	0.0%

Vertex Pharmaceuticals Inc. forecasts

VRTX ShareCast News

US close: Stocks rally on Eurozone developments	08-Nov-2011	ShareCast
US pre-open: CME relaxes margin rules in MF afte...	07-Nov-2011	ShareCast
US close: Banks fall, Wall Street finishes mixed	13-Oct-2011	ShareCast

More Vertex Pharmaceuticals Inc. ShareCast news

VRTX Top Newspaper Links

Trial Shows Cystic Fibrosis Drug Helped Ease Bre...	23-Feb-2011	New York Times
Drug approval	19-Jul-2004	The Scotsman
Investors are selling on good news or bad	30-Apr-2002	BayArea.com

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

VRTX Market Data

Currency	US Dollars
Share Price	$ 57.61
Change Today	$ -7.24
% Change	-11.16 %
52 Week High	$64.85
52 Week Low	$26.60
Volume	15,717,917
Shares Issued	211.06m
Market Cap	$12,159m
Beta	0.67
RiskGrade	525